Bank of New York Mellon’s Evolus EOLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.13M | Buy |
162,849
+19,685
| +14% | +$116K | ﹤0.01% | 3289 |
|
|
2026
Q1 | $588K | Buy |
143,164
+5,367
| +4% | +$26K | ﹤0.01% | 3521 |
|
|
2025
Q4 | $916K | Sell |
137,797
-5,023
| -4% | -$34K | ﹤0.01% | 3291 |
|
|
2025
Q3 | $877K | Buy |
142,820
+1,815
| +1% | +$14.2K | ﹤0.01% | 3283 |
|
|
2025
Q2 | $1.3M | Buy |
141,005
+5,300
| +4% | +$54.2K | ﹤0.01% | 2976 |
|
|
2025
Q1 | $1.63M | Sell |
135,705
-894
| -0.7% | -$11.7K | ﹤0.01% | 2785 |
|
|
2024
Q4 | $1.51M | Buy |
136,599
+13
| +0% | +$183 | ﹤0.01% | 2894 |
|
|
2024
Q3 | $2.21M | Sell |
136,586
-44,507
| -25% | -$622K | ﹤0.01% | 2700 |
|
|
2024
Q2 | $1.96M | Buy |
181,093
+35,760
| +25% | +$440K | ﹤0.01% | 2800 |
|
|
2024
Q1 | $2.03M | Sell |
145,333
-16,750
| -10% | -$218K | ﹤0.01% | 2751 |
|
|
2023
Q4 | $1.71M | Sell |
162,083
-1,937
| -1% | -$17.3K | ﹤0.01% | 2908 |
|
|
2023
Q3 | $1.5M | Buy |
164,020
+17,999
| +12% | +$161K | ﹤0.01% | 2958 |
|
|
2023
Q2 | $1.06M | Buy |
146,021
+22,473
| +18% | +$194K | ﹤0.01% | 3164 |
|
|
2023
Q1 | $1.05M | Buy |
123,548
+1,285
| +1% | +$11.6K | ﹤0.01% | 3114 |
|
|
2022
Q4 | $918K | Sell |
122,263
-15
| -0% | -$116 | ﹤0.01% | 3229 |
|
|
2022
Q3 | $983K | Sell |
122,278
-39,248
| -24% | -$416K | ﹤0.01% | 3210 |
|
|
2022
Q2 | $1.87M | Buy |
161,526
+54,500
| +51% | +$643K | ﹤0.01% | 2867 |
|
|
2022
Q1 | $1.2M | Buy |
107,026
+1,472
| +1% | +$12.5K | ﹤0.01% | 3199 |
|
|
2021
Q4 | $688K | Buy |
105,554
+1,847
| +2% | +$12.7K | ﹤0.01% | 3599 |
|
|
2021
Q3 | $791K | Buy |
103,707
+16,624
| +19% | +$172K | ﹤0.01% | 3540 |
|
|
2021
Q2 | $1.1M | Buy |
87,083
+10,981
| +14% | +$121K | ﹤0.01% | 3348 |
|
|
2021
Q1 | $988K | Sell |
76,102
-419
| -0.5% | -$3.86K | ﹤0.01% | 3335 |
|
|
2020
Q4 | $257K | Sell |
76,521
-7,020
| -8% | -$26.4K | ﹤0.01% | 3885 |
|
|
2020
Q3 | $326K | Sell |
83,541
-1,084
| -1% | -$3.96K | ﹤0.01% | 3696 |
|
|
2020
Q2 | $449K | Buy |
84,625
+2,682
| +3% | +$12.4K | ﹤0.01% | 3535 |
|
|
2020
Q1 | $341K | Sell |
81,943
-1,138
| -1% | -$9.64K | ﹤0.01% | 3545 |
|
|
2019
Q4 | $1.01M | Buy |
83,081
+33,310
| +67% | +$470K | ﹤0.01% | 3242 |
|
|
2019
Q3 | $778K | Buy |
49,771
+9,135
| +22% | +$150K | ﹤0.01% | 3305 |
|
|
2019
Q2 | $594K | Sell |
40,636
-15,677
| -28% | -$311K | ﹤0.01% | 3518 |
|
|
2019
Q1 | $1.27M | Buy |
56,313
+26,371
| +88% | +$570K | ﹤0.01% | 3023 |
|
|
2018
Q4 | $356K | Buy |
29,942
+9,575
| +47% | +$137K | ﹤0.01% | 3643 |
|
|
2018
Q3 | $379K | Buy |
20,367
+5,005
| +33% | +$108K | ﹤0.01% | 3755 |
|
|
2018
Q2 | $430K | Buy |
+15,362
| New | +$271K | ﹤0.01% | 3694 |
|
Other funds holding EOLS
PA
RHJA
SCM
N
AWM
Bank of New York Mellon's EOLS Position: Q2 2026 in Review
Bank of New York Mellon increased its Evolus (EOLS) stake by 14% in Q2 2026, buying an estimated $116K and bringing the position to 162,849 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #3289.
Bank of New York Mellon first reported a position in EOLS in Q2 2018 and has held it in 33 quarters since. The position peaked at $2.21M in Q3 2024. 67 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.
- Bank of New York Mellon held 162,849 shares of Evolus worth $1.13M as of Q2 2026.
- Bank of New York Mellon bought 19,685 Evolus shares in Q2 2026, an estimated $116K.
- Evolus made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3289 holding.
- Bank of New York Mellon first reported a position in Evolus in Q2 2018 and has held it in 33 quarters since.
- Bank of New York Mellon's Evolus position peaked at $2.21M in Q3 2024.
- 67 funds tracked by Wall St. Rank held Evolus as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.